Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive.
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive.
Tempus AI (TEM) pledged to buy cancer diagnostics outfit Personalis (PSNL) for $1.5 billion on Monday. But shares of both medtech companies skidded. The deal follows a rumor last week that Merck (MRK) and others, including potentially Tempus AI, had expressed interest in buying Personalis. Personalis makes a blood test that screens for circulating tumor DNA, a marker that a…
Sinergia Empresarial continuará el seguimiento de esta información sobre tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
